Earningsreport

Q4/2024 12/31/2024 EPS 0.300 ZacksConsensus 0.100 ActVsEst 0.200 - Beat

OptimizeRx Corporation  (OPRX) 
NASDAQ:AMEX Investor Relations: optimizerx.com/investors